US Patent Issued to Dynavax Technologies, The Government of the United States, as Represented by the Secretary of the Army on July 22 for "Immunogenicity of a CpG-adjuvanted recombinant plague vaccine" (California, Maryland Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,745, issued on July 22, was assigned to Dynavax Technologies Corp. (Emeryville, Calif.) and The Government of the United States, as Represented by the Secretary of the Army (Fort Detrick, Moldova).

"Immunogenicity of a CpG-adjuvanted recombinant plague vaccine" was invented by Robert S. Janssen (Palm Springs, Calif.), David Novack (Oakland, Calif.), Wai Kwan Chung (Hagerstown, Md.), Andrew M. Glenn (Germantown, Md.) and Lucy A. Ward (Silver Spring, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to immunogenic compositions comprising at least one Yersinia pestis (Y. pestis) antigen, an aluminum salt adjuvant, and an...